PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.\', \'Department of Internal Medicine B, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel.\', \'Department of Internal Medicine E, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel.\', \'Department of Internal Medicine A, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.\', \'Department of Internal Medicine D, Rabin Medical Center, Hasharon Campus, Petah Tikva, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fendo.2021.794382
?:hasPublicationType
?:journal
  • Frontiers in endocrinology
is ?:pmid of
?:pmid
?:pmid
  • 35002970
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.79
?:rankingScore_hIndex
  • 42
is ?:relation_isRelatedTo_publication of
?:title
  • A Randomized Clinical Trial of Linagliptin vs. Standard of Care in Patients Hospitalized With Diabetes and COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all